Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

AFG Cicero, A Colletti, G Bajraktari… - Nutrition …, 2017 - academic.oup.com
In recent years, there has been growing interest in the possible use of nutraceuticals to
improve and optimize dyslipidemia control and therapy. Based on the data from available …

Berberine and barberry (Berberis vulgaris): A clinical review

M Imenshahidi, H Hosseinzadeh - Phytotherapy Research, 2019 - Wiley Online Library
Barberry (Berberis vulgaris L.) has different medicinal applications in folk medicine of Iran.
Berberine, an alkaloid constituent of this plant, is present in the roots, rhizomes, stem, and …

[HTML][HTML] Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence

X Xu, H Yi, J Wu, T Kuang, J Zhang, Q Li, H Du… - Biomedicine & …, 2021 - Elsevier
The increased incidence of metabolic diseases (eg, diabetes and obesity) has seriously
affected human health and life safety worldwide. It is of great significance to find effective …

Biological activity of berberine—A summary update

A Och, R Podgórski, R Nowak - Toxins, 2020 - mdpi.com
Berberine is a plant metabolite belonging to the group of isoquinoline alkaloids with strong
biological and pharmacological activity. Currently, berberine is receiving considerable …

Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota

SR Ma, Q Tong, Y Lin, LB Pan, J Fu, R Peng… - Signal transduction and …, 2022 - nature.com
Abstract Trimethylamine-N-oxide (TMAO) derived from the gut microbiota is an atherogenic
metabolite. This study investigates whether or not berberine (BBR) could reduce TMAO …

The role of nutraceuticals in statin intolerant patients

M Banach, AM Patti, RV Giglio, AFG Cicero… - Journal of the American …, 2018 - jacc.org
Statins are the most common drugs administered for patients with cardiovascular disease.
However, due to statin-associated muscle symptoms, adherence to statin therapy is …

Research progress on berberine with a special focus on its oral bioavailability

CS Liu, YR Zheng, YF Zhang, XY Long - Fitoterapia, 2016 - Elsevier
The natural product berberine (BBR) has become a potential drug in the treatment of
diabetes, hyperlipidemia, and cancer. However, the oral delivery of BBR is challenged by its …

Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels?

AFG Cicero, F Fogacci, AP Stoian, M Vrablik… - Current atherosclerosis …, 2021 - Springer
Abstract Purpose of Review The aim of this review is to summarize the available clinical
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …

Berberine: a review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases

X Ai, P Yu, L Peng, L Luo, J Liu, S Li, X Lai… - Frontiers in …, 2021 - frontiersin.org
Traditional Chinese medicine plays a significant role in the treatment of various diseases
and has attracted increasing attention for clinical applications. Vascular diseases affecting …

Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach

AFG Cicero, F Fogacci, A Colletti - Food & function, 2017 - pubs.rsc.org
Cardiovascular diseases (CVDs) are one of the major causes of mortality and disability in
Western countries. Prevention is known to be the cornerstone to lessen the incidence of …